Batoclimab

DB16104Investigational

Batoclimab is under investigation in clinical trial NCT04428255 (A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP).

Mechanism: Pharmacologically active on IgG receptor FcRn large subunit p51
Curator reviewed
Also known as: Immunoglobulin g1(238-alanine, 239-alanine), anti-(human fcrn receptor) (human monoclonal hl161bkn .gamma.1-chain), disulfide with human monoclonal hl161bkn .lambda.-chain, dimer
Code names: HBM-9161 · HL161 · HL161BKN · IMVT-1401

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

11Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Batoclimab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.